Press Releases

Rho Experts Share Best Practices for Managing Risks in Clinical Trials

Rho, a full-service contract research organization (CRO) that helps pharmaceutical and biotechnology companies bring their products to market through high-quality clinical research services, will outline and provide tips on the U.S. Food and Drug Administration (FDA)’s new sponsor responsibilities for managing risks in clinical trials in an upcoming webinar, “Managing the Risks of Implementing E6R2.” The webinar will take place on Wednesday, March 25, from 1-2 p.m. EST.

COVID-19 RAPID DETECTION – ICENI DIAGNOSTICS OFFERS NEW APPROACH

Coronavirus could be detected using Iceni Diagnostics’ rapid, point-of-care screening technology, and distinguish between different viral strains

MR Solutions helps new ImPaKT facility become the best equipped containment laboratory in Canada

MR Solutions has installed a 3T PET-MR preclinical imaging system at Western University’s one of a kind ImPaKT Laboratory in Ontario.

Longhorn Vaccines & Diagnostics Encouraged by FDA to Help Solve Coronavirus Testing Bottleneck by Teaming PrimeStore MTM® with Diagnostic Developers

Coronavirus News: Longhorn’s PrimeStore MTM is the Only FDA Cleared Nucleic Transport Device that Inactivates Microbes Within the Device Allowing for Safe Transport and Testing

WCG’s WIRB-Copernicus IRB Announces New Program to Facilitate IRB Review of Research Protocols for COVID-19 (Coronavirus) Vaccines and Therapies

WIRB-Copernicus IRB will give priority to the institutional review board (IRB) review of potentially life-saving COVID-19 vaccines and medications and waive their initial protocol review fees. 

Beijing University of Chinese Medicine collaborates with Elsevier to launch first branch of traditional Chinese medicine taxonomy

First taxonomy branch focuses on acupuncture, and will open up new resources to modern biomedical sciences as global interest in Traditional Chinese Medicine grows

Signant Health Appoints Ian Jennings as Chief Commercial Officer

Profacgen Updated Its Immunogenicity Assay for Drug Development

Menarini Silicon Biosystems to Announce New Solutions for Advancing Liquid Biopsy in Clinical Research

Menarini Silicon Biosystems, the pioneer of liquid biopsy and rare cell technologies, announced today that it is developing several new products that could help advance precision medicine research by expanding the capabilities and applications of its CELLSEARCH and DEPArray technologies, for rare cells isolation and single cell analysis.

Recognition for excellence in research at regional research and innovation awards

Please find attached a press release on our big win at the North West Coast Research and Innovation Awards.

COVID-19 could be identified in minutes via mobile technology

Ubiquitome has developed Liberty 16, a mobile app connected device that can test for COVID-19 within 40 minutes at the factory, school or anywhere.

BioIVT Now Provides Same-day Delivery of Fresh Leukopaks and Immune Cell Products in the UK and Overnight to EU Locations

BioIVT’s acquisition of Clinical Trial Laboratory Services (CTLS) and its London donor center is enabling this rapid turnaround time for high quality blood-derived immune cells for cell and gene therapy research

WCG CenterWatch iConnect Selected as Patient Recruitment Management System for The Michael J. Fox Foundation’s Clinical Study Matching Tool, Fox Trial Finder

Improved technology and features will make it easier for patients living with Parkinson’s disease and healthy volunteers who want to advance medical research to find and connect to appropriate clinical trials

MR Solutions’ dry magnet MRI system for molecular imaging on display at EMIM 2020

MR Solutions will be displaying its latest dry magnet 3T to 9.4T preclinical, multi-modality MRI (with PET or SPECT) and new benchtop PET/CT systems to the imaging science community at the 15th European Molecular Imaging Meeting (EMIM 2020) on March 24 – 27, 2020 in Thessaloniki, Greece.

Certara’s Simcyp Division Acquires Modeling and Simulation Platform for Neurodegenerative Diseases from In Silico Biosciences, Inc.

This acquisition will spur the development of new drugs to treat complex neurodegenerative conditions, including Alzheimer’s and Parkinson’s disease.

The Pistoia Alliance’s UDM Project Reaches Major Milestone

Funding from Biovia, Elsevier, GSK, Novartis, and Roche (and recently BMS), helps build a comprehensive data model and file format for chemical reactions to support Lab of The Future and AI adoption

Spring Bank Announces Clinical Collaboration to Evaluate SB 11285 in Combination with PD-L1 Checkpoint Inhibitor in Patients with Advanced Solid Tumors

The release announces a new clinical collaboration with Roche (SIX:RO, ROG), to explore the co-administration of SB 11285, Spring Bank’s intravenously (IV)-administered STING (STimulator of INterferon Gene) agonist with Roche’s PD-L1 checkpoint inhibitor atezolizumab (Tecentriq®) in patients with advanced solid tumors.

Rare Disease Patient Platform Raremark Partners With TriNetX

TriNetX, the global health research network that revolutionizes clinical research and enables discoveries through the generation of real-world evidence (RWE), today announced that Raremark, a patient-data platform focused on rare disease, has partnered with the TriNetX network to bring more clinical trials to its community. 

Streck to present new tube at TRI-CON

Streck R&D Scientific Manager Dr. Nicholas George will give a presentation on our newest blood collection tube, RNA Complete BCT, at the 27th International Molecular Medicine Tri-Conference in San Francisco.

2 Industry Veterans Join TrialScope Connect™ Advisory Board

TrialScope announces the appointment of Craig Lipset and Scott Ballenger to the TrialScope Connect advisory board. TrialScope Connect is an online clinical trial recruitment collective designed address the challenges stakeholders face in accurately matching patients to trials. In advance of the platform’s launch, TrialScope is accepting partner applications from sponsors, healthcare data companies and patient advocacy groups.